| 30/08/18 | 10:58:50 | 30 Aug 2018 | | Holding(s) in Company | RNS |
| 28/08/18 | 13:45:12 | 28 Aug 2018 | | Holding(s) in Company | RNS |
| 22/08/18 | 10:41:11 | 22 Aug 2018 | | Director/PDMR Shareholding | RNS |
| 15/08/18 | 08:00:03 | 15 Aug 2018 | | Half-year Report | RNS |
| 23/07/18 | 10:00:01 | 23 Jul 2018 | | Notice of Results | RNS |
| 09/07/18 | 10:00:02 | 9 Jul 2018 | | Hikma enters licensing partnership with Perrigo | RNS |
| 02/07/18 | 17:56:18 | 2 Jul 2018 | | Total Voting Rights | RNS |
| 15/06/18 | 16:24:15 | 15 Jun 2018 | | Director/PDMR Shareholding | RNS |
| 08/06/18 | 12:50:53 | 8 Jun 2018 | | Director/PDMR Shareholding | RNS |
| 04/06/18 | 11:29:41 | 4 Jun 2018 | | Director/PDMR Shareholding | RNS |
| 04/06/18 | 10:00:01 | 4 Jun 2018 | | Hikma appoints Chief Transformation Officer | RNS |
| 01/06/18 | 12:34:16 | 1 Jun 2018 | | Total Voting Rights | RNS |
| 30/05/18 | 16:20:14 | 30 May 2018 | | Director/PDMR Shareholding | RNS |
| 30/05/18 | 10:00:01 | 30 May 2018 | | Hikma launches Methylergonovine Maleate Tablets | RNS |
| 23/05/18 | 11:20:36 | 23 May 2018 | | Director/PDMR Shareholding | RNS |
| 18/05/18 | 14:01:49 | 18 May 2018 | | AGM Results | RNS |
| 18/05/18 | 08:00:03 | 18 May 2018 | | Trading Statement | RNS |
| 17/05/18 | 14:45:01 | 17 May 2018 | | Director/PDMR Shareholding | RNS |
| 17/05/18 | 14:10:02 | 17 May 2018 | | Director/PDMR Shareholding | RNS |
| 15/05/18 | 15:26:12 | 15 May 2018 | | Director/PDMR Shareholding | RNS |
| 03/05/18 | 10:00:05 | 3 May 2018 | | Hikma launches Methotrexate Injection | RNS |
| 01/05/18 | 14:38:40 | 1 May 2018 | | Total Voting Rights | RNS |
| 26/04/18 | 14:40:20 | 26 Apr 2018 | | Holding(s) in Company | RNS |
| 25/04/18 | 11:41:12 | 25 Apr 2018 | | Block listing Interim Review | RNS |
| 24/04/18 | 10:00:07 | 24 Apr 2018 | | Hikma expands licensing agreement with Rovi | RNS |
| 20/04/18 | 10:00:03 | 20 Apr 2018 | | Hikma launches Dexrazoxane for Injection | RNS |
| 10/04/18 | 15:34:19 | 10 Apr 2018 | | Director/PDMR Shareholding | RNS |
| 29/03/18 | 10:00:01 | 29 Mar 2018 | | Hikma launch-Palonosetron Hydrochloride Injection | RNS |
| 20/03/18 | 09:00:01 | 20 Mar 2018 | | Hikma has launched Ritonavir Tablets USP | RNS |
| 19/03/18 | 15:50:52 | 19 Mar 2018 | | Director/PDMR Shareholding | RNS |
| 14/03/18 | 07:00:02 | 14 Mar 2018 | | Final Results | RNS |
| 12/03/18 | 07:00:06 | 12 Mar 2018 | | Update status on ANDA for generic Advair Diskus® | RNS |
| 09/03/18 | 09:21:54 | 9 Mar 2018 | | Block Listing Application | RNS |
| 27/02/18 | 12:23:02 | 27 Feb 2018 | | Notice of Results | RNS |
| 20/02/18 | 07:00:05 | 20 Feb 2018 | | Sigurdur Olafsson appointed CEO of Hikma | RNS |
| 13/02/18 | 16:43:08 | 13 Feb 2018 | | Holding(s) in Company | RNS |
| 08/02/18 | 12:41:06 | 8 Feb 2018 | | Director/PDMR Shareholding | RNS |
| 08/02/18 | 12:39:24 | 8 Feb 2018 | | Director/PDMR Shareholding | RNS |
| 08/02/18 | 12:37:14 | 8 Feb 2018 | | Director/PDMR Shareholding | RNS |
| 26/01/18 | 16:56:01 | 26 Jan 2018 | | Holding(s) in Company | RNS |
| 17/01/18 | 17:22:07 | 17 Jan 2018 | | Holding(s) in Company | RNS |
| 15/01/18 | 08:00:02 | 15 Jan 2018 | | Hikma Appoints Dr. Surendera Tyagi | RNS |
| 04/01/18 | 11:19:37 | 4 Jan 2018 | | Total Voting Rights | RNS |
| 19/12/17 | 09:00:01 | 19 Dec 2017 | | Hikma reaches licensing agreement with Celltrion | RNS |
| 12/12/17 | 09:59:02 | 12 Dec 2017 | | Holding(s) in Company | RNS |
| 11/12/17 | 09:33:58 | 11 Dec 2017 | | Holding(s) in Company | RNS |
| 01/12/17 | 09:28:37 | 1 Dec 2017 | | Total Voting Rights | RNS |
| 30/11/17 | 17:47:47 | 30 Nov 2017 | | Hikma Ventures- $20.5m Series C round for Prognos | RNS |
| 28/11/17 | 10:24:26 | 28 Nov 2017 | | Announcement | RNS |
| 27/11/17 | 13:38:22 | 27 Nov 2017 | | Hikma Ventures invests in Biolinq | RNS |
